Available as global and tech-only. This add-on panel is available to clarify findings on samples currently having flow cytometry analysis at NeoGenomics and is not available for stand-alone testing. Markers are cCD3, cCD22, cCD79, CD11b, CD123, CD34, CD45, CD117, cMPO, and nTdT (10 markers).
Used to diagnose AML and detect biphenotypic acute leukemia. Expression of CD11b is an unfavorable prognostic marker. CD123 can be added for specific cases.
Flow cytometry testing can be performed on bone marrow aspirate, peripheral blood, fresh bone marrow core biopsy, unfixed tissue, and body fluids. Please see full specimen requirements for either Standard Leukemia/Lymphoma Analysis or Extended Leukemia/Lymphoma Analysis as this add-on panel is available in combination with either of those full panels.
Specimens should be received at NeoGenomics within 72 hours from collection to assure sample integrity and acceptable cell viability. Note: New York State samples must be received within 48 hours from collection per NYS requirements. Refrigerate specimen. Do not freeze. Use cold pack for transport, making sure cold pack is not in direct contact with specimen.